Improved molecular diagnosis by the detection of exonic deletions with target gene capture and deep sequencing

Purpose:We aimed to demonstrate the detection of exonic deletions using target capture and deep sequencing data.Methods:Sequence data from target gene capture followed by massively parallel sequencing were analyzed for the detection of exonic deletions using the normalized mean coverage of individual exons. We compared the results with those obtained from high-density exon-targeted array comparative genomic hybridization and applied similar analysis to examine samples from patients with pathogenic exonic deletions.Results:Thirty-eight samples, each containing 2,134, 2,833, or 4,688 coding exons from different panels, with a total of 103,863 exons, were analyzed by capture–massively parallel sequencing and array comparative genomic hybridization. Ten deletions detected by array comparative genomic hybridization were all detected by massively parallel sequencing, whereas only two of three duplications were detected. We were able to detect all pathogenic exonic deletions in 11 positive cases. Thirty-one exonic copy number changes from nine perspective clinical samples were also identified.Conclusion:Our results demonstrated the feasibility of using the same set of sequence data to detect both point mutations and exonic deletions, thus improving the diagnostic power of massively parallel sequencing–based assays.Genet Med 17 2, 99–107.

[1]  J. Hirschhorn.  Genomewide association studies--illuminating biologic pathways. , 2009, The New England journal of medicine.

[2]  J. Lupski,et al.  Genomic Rearrangements and Gene Copy-Number Alterations as a Cause of Nervous System Disorders , 2006, Neuron.

[3]  Y. Chien,et al.  Clinical application of massively parallel sequencing in the molecular diagnosis of glycogen storage diseases of genetically heterogeneous origin , 2012, Genetics in Medicine.

[4]  Kenny Q. Ye,et al.  Mapping copy number variation by population scale genome sequencing , 2010, Nature.

[5]  H. Zhan,et al.  Targeted array CGH as a valuable molecular diagnostic approach: experience in the diagnosis of mitochondrial and metabolic disorders. , 2012, Molecular genetics and metabolism.

[6]  E. Banks,et al.  Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. , 2012, American journal of human genetics.

[7]  L. Wong,et al.  Application of oligonucleotide array CGH to the simultaneous detection of a deletion in the nuclear TK2 gene and mtDNA depletion. , 2010, Molecular genetics and metabolism.

[8]  L. Wong,et al.  Diagnostic approaches to apparent homozygosity , 2012, Genetics in Medicine.

[9]  Jing Wang,et al.  Utility of array CGH in molecular diagnosis of mitochondrial disorders. , 2012, Methods in molecular biology.

[10]  John Quackenbush,et al.  Exome sequencing-based copy-number variation and loss of heterozygosity detection: ExomeCNV , 2011, Bioinform..

[11]  Paul Medvedev,et al.  Computational methods for discovering structural variation with next-generation sequencing , 2009, Nature Methods.

[12]  Tom Walsh,et al.  Accurate and exact CNV identification from targeted high-throughput sequence data , 2011, BMC Genomics.

[13]  Jason Li,et al.  CONTRA: copy number analysis for targeted resequencing , 2012, Bioinform..

[14]  Avi Ma'ayan,et al.  Identification of small exonic CNV from whole-exome sequence data and application to autism spectrum disorder. , 2013, American journal of human genetics.

[15]  I. Tikhonova,et al.  Genetic diagnosis by whole exome capture and massively parallel DNA sequencing , 2009, Proceedings of the National Academy of Sciences.

[16]  P. Stankiewicz,et al.  Structural variation in the human genome and its role in disease. , 2010, Annual review of medicine.

[17]  L. Wong,et al.  Utilization of targeted array comparative genomic hybridization, MitoMet, in prenatal diagnosis of metabolic disorders. , 2011, Molecular genetics and metabolism.

[18]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[19]  A. C. Chinault,et al.  Application of dual-genome oligonucleotidearray-based comparative genomic hybridization to the molecular diagnosis of mitochondrial DNA deletion and depletion syndromes , 2009, Genetics in Medicine.

[20]  A. C. Chinault,et al.  Utility of oligonucleotide array-based comparative genomic hybridization for detection of target gene deletions. , 2008, Clinical chemistry.

[21]  Li Chieh Chen,et al.  Transition to Next Generation Analysis of the Whole Mitochondrial Genome: A Summary of Molecular Defects , 2013, Human mutation.

[22]  M. Hurles,et al.  Copy number variation in human health, disease, and evolution. , 2009, Annual review of genomics and human genetics.

[23]  Nicholas W. Wood,et al.  A robust model for read count data in exome sequencing experiments and implications for copy number variant calling , 2012, Bioinform..

[24]  L. Wong,et al.  Application of next generation sequencing to molecular diagnosis of inherited diseases. , 2014, Topics in current chemistry.

[25]  Agus Salim,et al.  Statistical challenges associated with detecting copy number variations with next-generation sequencing , 2012, Bioinform..

[26]  M. Rieder,et al.  Detection of structural variants and indels within exome data , 2011, Nature Methods.

[27]  Wei Zhang,et al.  Comprehensive next-generation sequence analyses of the entire mitochondrial genome reveal new insights into the molecular diagnosis of mitochondrial DNA disorders , 2013, Genetics in Medicine.

[28]  M. Daly,et al.  Genetic Mapping in Human Disease , 2008, Science.

[29]  Bradley P. Coe,et al.  Copy number variation detection and genotyping from exome sequence data , 2012, Genome research.

[30]  J. Ganesh,et al.  Expanded molecular features of carnitine acyl-carnitine translocase (CACT) deficiency by comprehensive molecular analysis. , 2011, Molecular genetics and metabolism.